オプション
家 AIプロンプト一覧 医療健康 処方審査アシスタント

処方審査アシスタント

{:__('collect %s',処方審査アシスタント)}

薬剤師が潜在的な薬物相互作用、用量異常、禁忌症を迅速に特定し、服薬安全性を向上するのを支援します。

プロンプト内容 コピー コピー

Act as a senior clinical pharmacist and review the following electronic prescription for compliance: The patient is a 65-year-old male diagnosed with Stage 2 hypertension and mild renal insufficiency (eGFR 45ml/min). Current medications include Amlodipine 5mg once daily, Aspirin 100mg once daily, and Ibuprofen 400mg three times daily. Focus on analyzing the nephrotoxic risk of the NSAID Ibuprofen in such patients, evaluate its synergistic effect on blood pressure control with antihypertensives, and check for potential drug-disease interactions. If risks are identified, provide specific dosage adjustment recommendations or alternative drug suggestions with justifications, ensuring the final regimen aligns with clinical guidelines and guarantees patient safety.

コピー コピー

シニア臨床薬剤師として、以下の電子処方のコンプライアンスを審査してください。患者は65歳の男性で、2期高血圧および軽度の腎不全(eGFR 45ml/min)と診断されています。現在の投与薬は、アムロジピン5mg 1日1回、アスピリン100mg 1日1回、イブプロフェン400mg 1日3回です。この種の患者におけるNSAIDであるイブプロフェンの腎毒性リスクを重点的に分析し、降圧薬との併用が血圧制御に与える相乗効果を評価し、潜在的な薬物-疾患相互作用を確認してください。リスクが特定された場合は、具体的な用量調整の推奨事項または代替薬の提案とその理由を提供し、最終的な治療計画が臨床ガイドラインに準拠し、患者の安全性を保証することを確保してください。

コピー コピー
コメント (0)
0/300

おすすめ

処方箋審査アシスタント
Act as a senior clinical pharmacist to review the provided patient prescription. Focus on analyzing drug interactions, contraindications, and dosage合理性, referencing the latest clinical guidelines to flag potential risks and provide optimization suggestions, ensuring patient medication safety.
処方箋審査アシスタント
Act as a senior clinical pharmacist to review the provided patient prescription. First, extract patient demographics, diagnosis, and all medication lists, focusing on drug-drug interactions, contraindications, and dosage appropriateness. Second, cross-reference with the latest clinical guidelines to identify potential adverse event risks or off-label usage. Finally, output the audit conclusion in a structured format, clearly highlighting any risk points and providing specific adjustment suggestions or warnings to ensure medication safety.
処方箋審査アシスタント
Act as a senior clinical pharmacist and review the provided patient prescription for compliance. Focus on analyzing drug-drug interactions, dosage appropriateness, and allergy contraindications, identifying potential risks, and providing adjustment suggestions to ensure the treatment plan aligns with the latest clinical guidelines.
処方箋審査アシスタント
Act as an intelligent audit assistant for a hospital pharmacy. Perform a deep compliance check on the provided electronic prescription data. First, extract patient demographics, diagnosis, and the list of prescribed medications, focusing on analyzing potential drug-drug interactions, especially for elderly patients or those with hepatic/renal impairment. Second, cross-reference medication contraindications with the patient's medical history and allergies, and identify any off-label usage. Finally, generate a structured audit report that clearly highlights potential risks, recommends safe alternative options or dosage adjustments, and flags items requiring manual pharmacist review, ensuring the prescription adheres to clinical medication guidelines before dispensing.
処方箋審査アシスタント
Act as a senior clinical pharmacist to review the provided electronic prescription for compliance. Focus on analyzing the patient's current medication list for potential drug interactions, contraindication conflicts, or dosages exceeding recommended ranges. If risks are identified, point out specific issues based on the latest clinical guidelines and provide adjustment suggestions; if no anomalies exist, confirm that the prescription meets standard treatment protocols.
処方審査アシスタント
Act as a senior clinical pharmacist and review the following patient prescription for compliance: The patient is a 65-year-old male diagnosed with Stage 2 hypertension and mild renal impairment (eGFR 45ml/min). The current prescription includes Amlodipine 5mg once daily, Valsartan 80mg once daily, and Ibuprofen 400mg three times daily for joint pain. Analyze if there are any drug interactions, whether the dosage requires adjustment based on renal function, and assess the risks of using NSAIDs in this context. Provide specific adjustment suggestions or alternative solutions to ensure medication safety.
OR